Skip to content
Screener

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
18.9%+8.4pp
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
-3.7%-13.0pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,612.1%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-3,658.5%-1,388pp
Septerna, Inc. logo
Septerna, Inc.SEPN
-49.9%-24.9pp
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-21.7%-4.5pp

Other financials

Income statement

See full
Revenue-
Operating income-$60.8M-106%
Net income-$56.6M-112%
EPS (diluted)-$1.19-58.7%

Balance sheet

See full
Cash & equivalents$63.6M+15.5%
Total debt$10.1M-14.8%
Total equity$422.9M+60.5%
Total assets$459.0M+60.8%

Cash flow

See full
Operating cash flow-$41.5M-65.4%
CapEx$78.0K+255%
Free cash flow-$41.5M-65.5%

Valuation

See full
Market cap$2.22B+317%
Enterprise value$2.17B+343%
P/S111.2×

Profitability

See full
Operating margin-767.6%
FCF margin-485.7%

Returns & leverage

See full
Return on equity-40%+22.3pp
Debt / equity0.0×
Current ratio15.7×-7.0×